文献库搜索 | GeneLibs

Liu(H),Su(Y),Zhang(J),Chen(X),Deng(K),Chen... Med 2026-05-08

...TP53 mutation/17p loss (Sonic Hedgehog, SHH), MYC amplification (group_3), and CDK6 activation (group_4), were strongly ...

Dong(Y),Xu(PP),Han(X),Wang(YQ),Chen(Y),Fan... Sci Bull (Beijing) 2026-04-30

...TP53 and TET2 in ENI-endoderm, and MYD88, PIM1, TBL1XR1, and CD79B in ENI-mesoderm. Notably, organotrophic migration exh...

Yilmaz(O),Aktaş(BK),Tezcan(N),Deshpande(V)... Histopathology 2026-03-29

...TP53 mutations in two cases, RB1 inactivation in the mixed tumour. Gallbladder carcinomas may rarely exhibit acinar diff...

Pederzoli(F),Pakula(H),Rodrigues(S),Garner... Gene 2026-06-20

...TP53 and PTEN. To advance our understanding of the role of specific genomic alterations in PCa, genetically engineered m...

Arizpe(D),Schoettler(PJ),Allen-Rhoades(WA)... Hum Pathol 2026-06-00

...TP53 alterations. These cases illustrate the pleiotropic role of DICER1 in renal tumorigenesis and the histologic hetero...

Gillis(N),Colin-Leitzinger(C),Tang(YH),Ott... Am J Hematol 2026-06-00

...TP53 mutations, MDS diagnosis, and higher-risk disease were associated with worse progression-free and overall survival;...

He(X),You(J),Deng(Y),Hu(Y),Qi(S),Li(Q),Yan... Front Endocrinol (Lausanne) None

...TP53, STAT3, and IL6, with biological processes related to oxidative stress. Further investigations show that DXR signif...

Rammeh(S),Ben Taher(Y),Ben Rekaya(M),Ben R... Cancer Pathog Ther 2026-07-00

...TP53) NM_000546.6:c.730G>T (p.Gly244Cys) and platelet-derived growth factor receptor alpha (PDGFRA) NM_006206.6:c.2525A>...

Saygin(C),Witkowski(MT),Cetin(S),Aldoss(I)... Blood Cancer Discov 2026-05-05

...TP53-mutant B-cell ALL, which necessitate tailored therapies. We explore novel strategies such as BH3 mimetics, menin in...

Jovein(MM),Meyer(T),Waterhouse(M),Pfeifer(... Ann Hematol 2026-03-30

...TP53 mutations (n = 9).Approximately 40% of patients with relapsed myeloid malignancies were successfully salvaged with ...